Cell Counting Kit-8 (CCK-8)
目录号 : GK10001细胞计数试剂盒-8(CCK-8)是一种即用型的单瓶溶液,可快速、可靠地测量各种化学物质对细胞存活率和毒性的敏感度。
Sample solution is provided at 25 µL, 10mM.
- Cell Host Microbe 32.1 (2024):48-62.PMID:38056458
- Adv Mater (2024):2401538.PMID:38738793
- Adv Mater (2023):2307193.PMID:37951210
- Adv Mater (2025):2413968.PMID:40223457
- Adv Fiber Mater (2025):1-17.
- Nat Microbiol (2025):1-16.PMID:39825096
- Cell Host Microbe 32.12 (2024):2195-2211.PMID:39610253
- Bioact Mater 51 (2025):825-840.PMID:40678266
- Brain Behav Immun 110 (2023):60-79.PMID:36754245
- Adv Sci 7.9 (2020):1902938.PMID:32382476
- Trends in Sciences 22.9 (2025):10417-10417.
- Nat Commun 14.1 (2023):3877.PMID:37391428
- Matter (2025).
- Nat Commun 15.1 (2024):72.PMID:38167723
- Cancer Res (2025).PMID:40729488
- ACS nano 17.7 (2023):7017-7034.PMID:36971310
- Adv. Fiber Mater. (2025):1-17.
- Nat Commun 15.1 (2024):3771.PMID:38704377
- Acs Nano (2025).PMID:40534228
- Nat Commun 16.1 (2025):6100.PMID:40603843
- Nat Commun 16.1 (2025):6807.PMID:40707439
- Nat Commun 16.1 (2025):6271.PMID:40623997
- Nat Commun 16.1 (2025):6532.PMID:40664636
- Cancer Commun (2024).PMID:38512764
- Nat Commun 16.1 (2025):7827.PMID:40846845
- Autophagy 18.5 (2022):1049-1061.PMID:34517786
- ACS nano (2025).PMID:39846120
- Nat Commun 16.1 (2025):7650.PMID:40819125
- Nat. Commun. 16.1 (2025):7856.PMID:40846856
- Acs Nano (2024).PMID:39361472
- Acs Nano (2025).PMID:40878028
- Nat Commun 16.1 (2025):3605.PMID:40240371
- Autophagy just-accepted (2024).PMID:39007910
- Acta Pharm Sin B (2025).
- Adv-Sci 10.27 (2023):2302640.PMID:37485650
- Adv Sci 10.31 (2023):2301120.PMID:37688357
- Adv Sci (2023):2301107.PMID:37097746
- Nat. Commun. 16.1 (2025):2551.
- Adv Sci (2024):2401845.PMID:38757623
- Brain Behav Immun (2024).PMID:38565398
- Acta Pharm Sin B (2025).
- Cancer Commun 43.5 (2023):582-612.PMID:37005481
- Adv Sci (2025):2417374.PMID:40213972
- Adv Sci (2025):e08503.PMID:40685704
- Adv Sci (2024):2404365.PMID:39159143
- Adv Sci (2024):2402450.PMID:38952061
- Adv Sci (2025):2417318.PMID:40472230
- Adv Sci (2025):e02781.PMID:40886326
- Adv Sci (2025):e04192.PMID:40536697
- Adv Sci (2025):2413936.PMID:40047320
- Microbiome 12.1 (2024):152.PMID:39152482
- Sci Adv 10.10 (2024):eadg7380.PMID:38457499
- Adv Sci (2025):2417374.PMID:40213972
- Advanced Science (2025):e08503.PMID:40685704
- Biomaterials (2025):123539.PMID:40664088
- Small (2024):2407674.PMID:39363789
- J Adv Res (2023).PMID:36933884
- J Med Virol 95.10 (2023):e29171.PMID:37830751
- J Exp Clin Canc Res 41.1 (2022):293.PMID:36199122
- J Exp Clin Canc Res 44.1 (2025):193.PMID:40616124
- Small 21.3 (2025):2409121.PMID:39544127
- Carbohyd Polym (2025):124445.
- Nano Today 61 (2025):102560.
- Theranostics 15.15 (2025):7802.PMID:40756352
- Biomaterials 325 (2026):123539.PMID:40664088
- J Nanobiotechnol 23.1 (2025):537.PMID:40707955
- J Adv Res (2025).PMID:40373960
- Sci Adv 11.33 (2025):eadx3851.PMID:40802748
- J Nanobiotechnol 23.1 (2025):533.PMID:40691611
- Theranostics 15.15 (2025):7802.PMID:40756352
- Emerg Microbes Infec 12.1 (2023):2204164.PMID:37060263
- Exp Mol Med (2025):1-15.PMID:40887495
- J Exp Clin Canc Res 44.1 (2025):193.PMID:40616124
- Theranostics 15.14 (2025):6919.PMID:40585994
- Biomaterials (2025):123335.PMID:40222258
- Theranostics 15.15 (2025):7820.PMID:40756354
- Water Res (2024):121379.PMID:38422694
- Science Advances 11.31 (2025):eadx6732.PMID:40737412
- Cell Death Differ 30.10 (2023):2293-2308.PMID:37608075
- Theranostics 14.16 (2024):6161.PMID:39431016
- Mater Horiz (2024).PMID:39189308
- J Control Release (2025):114187.PMID:40902670
- Mol. Ther. 33.3 (2025):1134.PMID:39810420
- Small Methods (2024):2400223.PMID:38602202
- Redox Biol (2025):103771.PMID:40669208
- Gut Microbes 17.1 (2025):2446376.PMID:39718561
- Mater Horiz (2024).PMID:39189308
- Mol Ther (2025).PMID:39810420
- Gut Microbes 16.1 (2024):2347757.PMID:38773738
- J Hazard Mater (2024):135904.PMID:39303616
- Engineering-Prc (2025).
- Redox Biology (2025):103870.
- Theranostics 12.7 (2022):3488.PMID:35547749
- Environ Sci Technol (2024).PMID:39364562
- Research-China (2025).
- J Adv Res (2025).PMID:40373960
- Water Res (2024):122403.PMID:39278116
- Research-China 8 (2025):0823.PMID:40822127
- Research 8 (2025):0854.PMID:40927753
- Research 8 (2025):0860.PMID:40862056
- Cell Discov 6.1 (2020):96.PMID:33349633
- J Exp Clin Canc Res 43.1 (2024):91.PMID:38528516
- J Exp Clin Canc Res 43.1 (2024):187.PMID:38965580
- J Immunother Cancer 12.3 (2024):e008054.PMID:38429070
- Cardiovascular Diabetology 24.1 (2025):338.PMID:40826463
- Environmental Science & Technology (2025).PMID:40743993
- Cell Rep Med 6.9 (2025).PMID:40961922
- J Control Release 365 (2024):301-316.PMID:38007195
- J Control Release 373 (2024):749-765.PMID:39084465
- Clin Transl Med 14.1 (2024):e1539.PMID:38224186
- Research-China (2025).
- J Exp Clin Canc Res 39 (2020):1-13.PMID:32028978
- Environ Sci Technol (2025).PMID:40743993
- Cell Discov 6.1 (2020):96.PMID:33349633
- EBioMedicine 99 (2024).PMID:38101299
- Redox Biol (2023):102983.PMID:38064762
- Medcomm 6.9 (2025):e70365.PMID:40919132
- Environ Sci Technol 56.21 (2022):15096-15107.PMID:36099323
- J Control Release 360 (2023):647-659.PMID:37406817
- Acta Biomater 157 (2023):321-336.PMID:36481504
- J Exp Clin Canc Res 41 (2022):1-15.PMID:34980201
- J Control Release 349 (2022):254-268.PMID:35803328
- J Adv Res (2025).
- J Exp Clin Canc Res 44.1 (2025):1-19.PMID:40069844
- J Exp Clin Canc Res 41.1 (2022):1-15.PMID:34980201
- J Control Release 359 (2023):12-25.PMID:37244298
- J Control Release 379 (2025):89-104.PMID:39756690
- J Exp Clin Canc Res 41 (2022):1-15.PMID:34980201
- Sci Total Environ 878 (2023):162942.PMID:36940749
- Redox Biol 62 (2023):102663.PMID:36924682
- J Nanobiotechnol 22.1 (2024):1-15.PMID:38790037
- Adv Healthc Mater (2024):2402877.PMID:39434433
- Adv Healthc Mater (2025):e01742.PMID:40751487
- J Nanobiotechnol 20.1 (2022):1-20.PMID:36123708
- Mater Today Bio (2025):102288.
- J Nanobiotechnol 22.1 (2024):1-21.PMID:38448959
- J Nanobiotechnol 20.1 (2022):1-20.PMID:36123708
- Sci Total Environ 897 (2023):165514.PMID:37451464
- Acta Biomater (2024).PMID:38452962
- Cardiovasc Res 121.2 (2025):324-338.PMID:39658102
- Adv Healthc Mater (2024):2401061.PMID:38849128
- J Nanobiotechnol 23.1 (2025):1-22.PMID:39871272
- Environ Health Persp 131.6 (2023):067004.PMID:37267060
- J Immunother Cancer 13.6 (2025):e011717.PMID:40473272
- J Immunother Cancer 12.10 (2024):e009416.PMID:39455095
- Cancer Lett (2024):216765.PMID:38408604
- Mater Today Bio (2025):101901.PMID:40520551
- Adv Healthc Mater (2025):2500845.PMID:40400499
- Cancer Lett 620 (2025):217685.PMID:40158720
- Rare Met. (2025):1-23.
- Mater Today Bio 32 (2025):101703.PMID:40230646
- Acta Biomater (2025).PMID:40946735
- Cell Death Dis 16.1 (2025):502.PMID:40624028
- Food Chem (2025):146103.PMID:18830861
- J Neuroinflamm 20.1 (2023):1-16.PMID:36944954
- Adv Healthc Mater 12.9 (2023):2202785.PMID:36541060
- Adv Healthc Mater 11.8 (2022):2102395.PMID:34874119
- ENGINEERING-PRC (2025).
- Adv Healthc Mater 13.8 (2024):2303215.PMID:38112062
- Pharmacol Res 187 (2023):106563.PMID:36410674
- Cell Death Dis 16.1 (2025):634.PMID:40841355
- J Nanobiotechnol 21.1 (2023):354.PMID:37775761
- Cell Death Dis 16.1 (2025):502.PMID:40624028
- Cell Death Dis 16.1 (2025):493.PMID:40615369
- Cell Death Dis (2025):680.PMID:41053142
- View-China (2025):20240103.
- Biomark Res 11.1 (2023):3PMID:36611218
- Liver Int 43.4 (2023):840-854.PMID:36737842
- Cancer Lett (2024):217418.PMID:39725146
- Genes Dis (2025):101732.PMID:37815978
- Acs Appl Mater Inter (2024).PMID:38345297
- Food Chem (2024):139505.PMID:38703732
- Acta Biomater (2025).PMID:39952883
- Cell Mol Biol Lett 29.1 (2024):103.PMID:38997648
- J Colloid Interf Sci (2025):.PMID:39755016
- Front Immunol 14 (2023):1130308.PMID:37006248
- Cancer Lett 611 (2025):217418.PMID:39725146
- Int J Biol Macromol (2025):146723.PMID:40784392
- Acta Biomater 113 (2020):393-406.PMID:32629189
- Brit J Cancer (2024):1-9.PMID:38594370
- Acs Appl Mater Inter 15.11 (2023).PMID:36897565
- Cell Death Dis 13.5 (2022):497.PMID:35614040
- Cell Mol Life Sci 80.3 (2023):61.PMID:36763212
- Cell Mol Life Sci 79.7 (2022):382.PMID:35751755
- ACS Appl Mater Inter 14.13 (2022).PMID:35344348
- Acs Appl Mater Inter 15.32 (2023).PMID:37542453
- J Colloid Interf Sci (2025):137652.
- CANCER LETT (2025):217685.
- Pharmacol Res 195 (2023):106877.PMID:37524154
- Environ Pollut 338 (2023):122581.PMID:37748638
- Mater. Today Bio (2025):101703.
- Mol Ther-Nucl Acids 31 (2023):703-716.PMID:36923951
- Pharmacol Res (2024):107460.PMID:39393436
- Acta Biomater (2025).PMID:40024424
- Pharmacol Res 180 (2022):106225.PMID:35452801
- Environ Pollut 334 (2023):122148.PMID:37419204
- Cell Death Dis 13.10 (2022):858.PMID:36209201
- Int J Biol Macromol (2024):133667.PMID:38969038
- Int J Biol Macromol (2025):141767.
- Phytomedicine 122 (2024):155091.PMID:37844378
- Mater Today Bio (2025):101901.
- Cell Death Dis 12.8 (2021):779.PMID:34365463
- Int J Biol Sci 21.2 (2025):614.PMID:39781455
- Cell Death Dis 13.3 (2022):233.PMID:35288538
- Biomater Sci-UK 10.17 (2022):5006-5017.PMID:35815806
- Sci China Life Sci (2025):1-11.PMID:39821161
- Sci Rep-Uk 15.1 (2025):1-16.PMID:40436970
- Int J of Bio Macromol (2024):132103.PMID:38719011
- Sci Rep-Uk 15.1 (2025):1-14.PMID:40450025
- Free Radical Bio Med 190 (2022):202-215.PMID:35985562
- Phytomedicine (2023):155270.PMID:38096717
- Phytomedicine (2025):157223.PMID:40929882
- Int J Biol Macromol (2024):135562.PMID:39276884
- Free Radical Bio Med (2025).PMID:40782974
- Phytomedicine 122 (2024):155091.PMID:37844378
- Acs Sensors (2024).PMID:38958530
- Mater Today Bio (2024):101019.PMID:38516170
- Acs Appl Mater Inter (2025).PMID:39853325
- Antivir Res 205 (2022):105381.PMID:35835291
- Cell Mol Life Sci 81.1 (2024):143.PMID:38493426
- Cell Commun Signal 22.1 (2024):1-19.PMID:38454413
- Int J Biol Macromol (2025):140602.PMID:39922352
- Cell Death Dis 12.4 (2021):408.PMID:33859186
- Int J Biol Macromol (2025):148033.PMID:41038469
- Int J Biol Macromol(2023):125130.PMID:37263336
- Int J Biol Macromol 220 (2022):371-384.PMID:35970372
- Oncogene (2023):1-13.PMID:37138031
- Free Radical Bio Med 188 (2022):404-418.PMID:35787451
- Acta Pharmacol. Sin. (2025):1-13.PMID:40903541
- Int J Biol Macromol 224 (2023):797-809.PMID:36283555
- Cell Death Dis 15.11 (2024):826.PMID:39543094
- Int J Biol Macromol (2025):147167.PMID:40889659
- Int J Biol Macromol (2025):147767.PMID:40972920
- Cell Mol Life Sci 81.1 (2024):32.PMID:38214780
- Int J Biol Macromol (2024):136818.PMID:39447809
- INT J BIOL SCI 21.7 (2025):3099-3121.
- Int. J. Biol. Macromol. (2025):143759.
- Environ Res (2024):118221.PMID:38246300
- CANCER IMMUNOL RES (2025).PMID:40323348
- Int J Biol Macromol (2024):135979.PMID:39332550
- Cell Commun Signal 22.1 (2024):293.PMID:38802896
- Acs Omega (2025).
- Cell Commun Signal 22.1 (2024):1-23.PMID:39696352
- Int J Biol Macromol (2024):131928.PMID:38688339
- Int J Biol Macromol 222 (2022):1789-1800.PMID:36191790
- Nanoscale Horiz (2025).
- Int. J. Biol. Markers (2025):143683.PMID:40318724
- Cell Mol Biol Lett 29.1 (2024):83.PMID:38822277
- Phytomedicine (2025):157371.
- Front Immunol 16 (2025):1569210.PMID:40396173
- Int Immunopharmacol 158 (2025):114885.PMID:40383096
- Int J Biol Sci 21.4 (2025):1837-1851.
- Acs Appl Mater Inter (2024).PMID:39320506
- Acs Appl Mater Inter (2024).PMID:39448903
- Int J Biol Macromol (2025):140374.PMID:39880265
- Int J Biol Macromol (2025):145368PMID:40541884
- Int J Biol Macromol (2025):140632.PMID:39909240
- Phytomedicine 118 (2023):154944.PMID:37393830
- Acs Appl Mater Inter (2025).PMID:40025657
- Int J Biol Macromol (2024):137561.PMID:39537068
- Food Res Int 204 (2025):115940.PMID:39986784
- Int. J. Biol. Macromol. (2025):142238.PMID:40112979
- Cell Death Dis 16.1 (2025):240.PMID:40175350
- Int J Biol Macromol (2024):129172.PMID:38176496
- Sci Rep-Uk 15.1 (2025):1-17.PMID:40383858
- Free Radical Bio Med (2025).PMID:40782974
- Int J Biol Macromol 306 (2025):141410.PMID:40010477
- Int J Biol Macromol (2025):141146.PMID:39986528
- Npj Precis Oncol 9.1 (2025):269.PMID:40753128
- Phytother Res (2024).PMID:38558449
- Ecotox Environ Safe 262 (2023):115161.PMID:37356398
- Cell Death Discov 10.1 (2024):7.PMID:38182573
- J Cell Physiol 238.1 (2023):195-209.PMID:36436184
- Ecotox Environ Safe 266 (2023):115571.PMID:37837696
- Biomed Pharmacother 158 (2023):114118.PMID:36527845
- J Gastroenterol (2023):1-14.PMID:37150773
- Front Cell Dev Biol 9 (2021):696558.PMID:34447749
- Anal Chem 95.31 (2023):11664-11671.PMID:37495553
- Front Immunol 14 (2023).PMID:37662906
- Biomed Pharmacother 165 (2023):115261.PMID:37549461
- Front Cell Dev Biol 9 (2021):749210.PMID:34676217
- Biomed Pharmacother 129 (2020):110315.PMID:32554246
- Biomed Pharmacother 162 (2023):114602.PMID:37018993
- Phytother Res 37.10 (2023):4639-4654.PMID:37394882
- Bba Mol Basis Dis 1869.7 (2023):166725.PMID:37127173
- Life Sci 308 (2022):120925.PMID:36057399
- Virol Sin (2023).PMID:37331658
- Front Immunol 14 (2023):1111494.PMID:36817451
- Stem Cell Res Ther 16.1 (2025):239.PMID:40361250
- Free Radical Bio Med (2024).PMID:38367927
- Front Immunol 13 (2022):902515.PMID:35874682
- Front Immunol 13 (2022):986214.PMID:36341437
- Stem Cell Res Ther 16.1 (2025):119.PMID:40050973
- Clin Epigenetics 14.1 (2022):1-12.PMID:35414117
- J Environ Chem Eng 13.3 (2025):116286.
- Int J Biol Macromol 211 (2022):128-139.PMID:35561854
- Ecotox Environ Safe 270 (2024):115813.PMID:38113798
- Int J Nanomed (2025):11295-11314.PMID:40989888
- Int J Biol Macromol 211 (2022):128-139.PMID:35561854
- Oncogene (2025):1-17.PMID:40968253
- Oncogenesis 11.1 (2022):21.PMID:35487890
- Neural Regen Res (2025):10-4103.PMID:41017682
- Mater Today Bio 15 (2022):100264.PMID:35517578
- Neural Regen Res (2025):10-4103.PMID:41017725
- Cell Death Discov 11.1 (2025):427.PMID:41052997
- J Med Chem (2024).PMID:38315032
- Cell Death Discov 10.1 (2024):97.PMID:38402198
- Antioxid Redox Sign 37.13 (2022):867-886.PMID:35350885
- Wirel Commun Mob Com 2 (2022):3.PMID:36120596
- Plos Pathog 19.10 (2023):e1011702.PMID:37801439
- Life Sci 312 (2023):121092.PMID:36279968
- Biomed Pharmacother 168 (2023):115751.PMID:37879214
- Food Chem Toxicol 148 (2021):111972.PMID:33421461
- Biomed Pharmacother 130 (2020):110566.PMID:32755793
- Cell Death Discov 9.1 (2023):415.PMID:37968255
- Bba-Mol Basis Dis 1869.1 (2023):166571.PMID:36244542
- J Med Chem 65.4 (2021):2794-2808.PMID:33872498
- Bioeng Transl Med 8.3 (2023):e10475.PMID:37206234
- Journal of Animal Science and Biotechnology 16.1 (2025):121.PMID:40887645
- Cell Biol Toxicol 38.6 (2022):1121-1136.PMID:35348966
- Diabetes (2025):db250132.PMID:40906541
- J Mater Chem B 11.16 (2023):3740-3751.PMID:37067505
- Eur J Med Chem 238 (2022):114458.PMID:35635946
- Fertil Steril (2023).PMID:37178109
- Plos Pathog 17.3 (2021):e1009393.PMID:33684175
- Front Nutr 9 (2022):812623.PMID:35419394
- Front Cell Dev Biol 10 (2022):850708.PMID:35592246
- Antioxidants-Basel 14.8 (2025):915.
- Biomed Pharmacother 174 (2024):116470.PMID:38565061
- Stem Cell Res Ther 16.1 (2025):119.PMID:40050973
- Phytomedicine (2025):156928.
- Phytomedicine (2025):156598.
- Ecotox Environ Safe 280 (2024):116579.PMID:38865940
- J Med Virol 96.11 (2024):e70049.PMID:39558699
- Int J Nanomed (2025):4535-4550.PMID:4023652
- Food Res Int (2025):115940.
- Phytomedicine 130 (2024):155744.PMID:38763011
- Npj Precis Oncol 9.1 (2025):112.PMID:40240582
- Emerg Microbes Infec (2025):2522877.PMID:40536397
- J Med Chem (2025).PMID:39842821
- J Med Virol 97.3 (2025):e70267.
- Biomed Pharmacother 189 (2025):118248.PMID:40561593
- Biomed Pharmacother 177 (2024):117037.PMID:38959602
- J Med Chem (2025).PMID:40500735
- Oncogene (2025):1-15.PMID:39920289
- Cell Rep 44.3 (2025).PMID:39977268
- Int J Nanomed 20 (2025):293-308.
- Stem Cell Res Ther 15.1 (2024) 385.PMID:39468662
- Biomed Pharmacother 188 (2025):118217.PMID:40435839
- Biomed Pharmacother 122 (2020):109690.PMID:31786468
- J Polym Environ (2025):1-16.
- Cell Death Discov 11.1 (2025):1-16.PMID:40399275
- Phytomedicine (2025):156860.
- Phytomedicine (2024):155859.PMID:38972239
- Stem Cell Res Ther 16.1 (2025):1-18.PMID:40361250
- Biomed Pharmacother 184 (2025):117907.PMID:39978030
- Iscience (2025).
- Cell Death Discov 11.1 (2025):1-12.PMID:40456746
- Chem-Biol Interact (2025):111576.PMID:40456372
- Inflamm Res 74.1 (2025):1-22.PMID:40439750
- Phytomedicine (2025):156515.PMID:39983438
- Acta Pharmacol Sin (2025):1-15.PMID:39984622
- Arch Toxicol (2025):1-17.PMID:40464975
- Biomed Pharmacother 179 (2024):117415.PMID:39265236
- Stem Cell Res Ther 10.1 (2019):1-14.PMID:31847890
- Stem Cell Res Ther 15.1 (2024):1-18.PMID:39267160
- Embo Rep (2025):1-23. PMID:40185977
- Brit J Pharmacol (2024).PMID:38715438
- Nanoscale 16.17 (2024):8479-8494.PMID:38590261
- AGING DIS 17.1 (2026):2.PMID:40072367
- Int J Nanomed (2024):13183-13199.PMID:39664759
- J Med Chem (2024).PMID:39292661
- J. Environ. Chem. Eng. (2025):116286.
- J Med Chem 68.3 (2025):3356-3372.PMID:39842821
- Cancer Cell Int 20 (2020):1-14.PMID:33292221
- Aging (Albany NY) 16.11 (2024):9625.PMID:38829771
- J Agr Food Chem (2025).PMID:39962827
- Apoptosis (2025):1-17.PMID:40347321
- J Transl Med 22.1 (2024):1-19.PMID:39107788
- Front Immunol 15 (2024):1455996.PMID:39376562
- Front Immunol 15 (2024):1375781.PMID:39391314
- Front Immunol 16 (2025):1569210.
- Front Pharmacol 14 (2023):1168393.PMID:37124212
- Front Immunol 15 (2024):1455996.PMID:39376562
- Int J Pharmaceut (2023):123142.PMID:37328119
- Front Pharmacol 13 (2022):1015693.PMID:36210855
- Lab Invest 102.4 (2022):411-421.PMID:34775495
- Cell Death Discov 11.1 (2025):74.PMID:39988672
- Aging (Albany NY) 13.17 (2021):21712.PMID:34518442
- Aging (Albany NY) 15.12 (2023):5673.PMID:37387540
- Cancer Cell Int 23.1 (2023):142.PMID:37468908
- Front Cell Dev Biol 10 (2022):787730.PMID:35445026
- Biochem Pharmacol (2024):116044.PMID:38336157
- Microbiol Res (2024):127927.PMID:39393129
- Mol Med 31.1 (2025):1-15.PMID:40369420
- J Invest Dermatol (2025).PMID:39892773
- J Transl Med 23.1 (2025):131.PMID:39885513
- Int J Mol Sci 22.21 (2021):11893.PMID:34769322
- Front Oncol 12 (2022):858598.PMID:35321435
- Mol Med 30.1 (2024):14.PMID:38254010
- J Agr Food Chem 73.14 (2025).PMID:40152883
- Apoptosis (2024):1-19.PMID:39097858
- Cns Neurosci Ther (2023).PMID:37452510
- Front Pharmacol 13 (2022):819826.PMID:35645824
- Int J Mol Med 54.6 (2024):1-17.PMID:39364745
- Front Pharmacol 13 (2022):965131.PMID:36249790
- Front Pharmacol 13 (2022):972397.PMID:36188529
- Front Immunol 15 (2024):1375781.PMID:39391314
- J Agr Food Chem (2025).PMID:40152883
- Front Oncol 12 (2022):770628.PMID:35372056
- Resp Res 24.1 (2023):216.PMID:37674165
- Front Pharmacol 13 (2022):946193.PMID:36091823
- Front Pharmacol 12 (2021):649398.PMID:34335241
- Cancer Cell Int 21 (2021):1-12.PMID:34281530
- Int J Mol Sci 24.22 (2023):16503.PMID:38003694
- Mol Cell Proteomics (2025):100930.PMID:40024376
- J Transl Med 22.1 (2024):1-15.PMID:39256832
- MOL MED 31.1 (2025):126.PMID:40186145
- J Agr Food Chem (2023).PMID:37922022
- Microbiol Res (2025):128183.
- Ecotox Environ Safe 233 (2022):113315.PMID:35189521
- Mbio (2023):e01688-23.PMID:37882780
- Front Pharmacol 12 (2021):673263.PMID:34108880
- Cells 11.24 (2022):4094.PMID:36552856
- Cancer Gene Ther 29.8-9 (2022):1228-1239.PMID:35115683
- J Transl Med 22.1 (2024):1-17.PMID:39267037
- Phytother. Res. 39.3 (2025):1355-1371.PMID:39764683
- Bba-Mol Basis Dis (2024):167210.PMID:38704001
- Int J Mol Sci 23.22 (2022):14306.PMID:36430782
- Cancer Gene Ther (2021)1-12.PMID:33888871
- Front. Immunol. 16 (2025):1556715.
- J Agr Food Chem (2025).PMID:40017402
- Front Cell Dev Biol 9 (2022):793793.PMID:35155447
- J Mater Chem B (2024).PMID:39119756
- Int J Mol Sci 23.24(2022):16045.PMID:36555684
- Biomater Adv (2025):214257.PMID:40023084
- Biomater Adv (2024):214069.PMID:39447240
- J Enzym Inhib Med Ch 39.1 (2024):2288810.PMID:38059334
- BREAST CANCER RES 27.1 (2025):61.PMID:40270028
- Mol Neurobiol 58 (2021):1990-2004.PMID:33411316
- Mol Med 30.1 (2024):1-18.PMID:39266965
- Jci insight 9.15 (2024):PMID:38935435
- Aging (Albany NY) 13.3 (2021):4482.PMID:33495411
- Biomacromolecules (2025).
- J Invest Dermatol (2025).PMID:39892773
- Front Pharmacol 12 (2021):610158.PMID:33762939
- Front Immunol 16 (2025):1521965.PMID:40191190
- Front Oncol 12 (2022):858598.PMID:35321435
- Int-Immunopharmacol 124 (2023):110809.PMID:37690240
- Liver Int 45.2 (2025):e16246.PMID:39821525
- Talanta (2025):127591.PMID:39847915
- Int Immunopharmacol 132 (2024):111870.PMID:38547771
- Front Cell Dev Biol (2023):1161541.PMID:37325570
- Am J Cancer Res 13.5 (2023):2135.PMID:37293170
- J Agr Food Chem 70.50 (2022):15763-15775.PMID:36472370
- Int J Mol Med 55.3 (2025):1-14.PMID:39791203
- Int J Biochem Cell B 153 (2022):106317.PMID:36283586
- Int J Mol Med 55.4 (2025):1-16.PMID:39918010
- Ecotox Environ Safe 287 (2024):117331.PMID:39547060
- Mol Med 31.1 (2025):188.PMID:40369420
- Apoptosis 28.3-4 (2023):414-431.PMID:36482019
- Int Immunopharmacol 113 (2022):109342.PMID:36327871
- Acs Biomater Sci Eng (2025).PMID:40891613
- Int J Biochem Cell B 153 (2022):106317.PMID:36283586
- Cell Biosci 15.1 (2025):95.PMID:40615893
- Am J Chinese Med (2024):1-23.PMID:38490807
- Lab Chip (2024).PMID:38939907
- Acs Biomater Sci Eng (2024).PMID:38446137
- Int Immunopharmacol 121 (2023):110413.PMID:37301119
- Exp Neurol 359 (2023):114266.PMID:36336032
- Front Pharmacol 13 (2022):1043022.PMID:36588728
- Colloid Surface B 222 (2023):113119.PMID:36621177
- Front Bioeng Biotech 12 (2024):1361682.PMID:38562665
- J Nutr Biochem (2024):109678.PMID:38844080
- Front Immunol 16 (2025):1591912.
- Cancer Cell Int 24.1 (2024):123.PMID:38566075
- Biochem Pharmacol 213 (2023):115592.PMID:37196680
- Chinese Med J-Peking 136.05 (2023):556-564.PMID:36939243
- Stem Cell Transl Med (2024):szae020.PMID:38530131
- Phytother Res (2023).PMID:37246830
- Cells 11.23 (2022):3816.PMID:36497076
- Front Immunol 16 (2025):1619733.PMID:40842984
- Int Immunopharmacol 131 (2024):111922.PMID:38522137
- Cell Mol Life Sci 81.1 (2024):265.PMID:38880863
- Front Oncol 13 (2023):1132424.PMID:37251940
- Front Immunol 16 (2025):1618342.
- Am J Physiol-Cell Ph (2024).PMID:38525543
- Molecular Therapy Oncology 32.2 (2024).PMID:38948919
- Acs Biomater Sci Eng (2024).PMID:38445959
- Jci Insight (2024). PMID:38935435
- Front Pharmacol 13 (2022):927488.PMID:35935870
- Front Oncol 13 (2023):1120103.PMID:36959804
- Antioxid Redox Sign (2025).PMID:40455659
- Int J Mol Med 55.3 (2025):1-17.
- Phytother Res (2023).PMID:37086359
- Mol Med 31.1 (2025):200.PMID:40405066
- Life Sci (2024):122483.PMID:38307238
- Mol Neurobiol 59.12 (2022):7075-7094.PMID:36083519
- Int J Mol Med 55.3 (2025):45.PMID:39791203
- Front Immunol 15 (2024):1455996.PMID:39376562
- Mol Med 31.1 (2025):1-15.PMID:40405066
- Mol Med 30 (2024):260.PMID:39707194
- Front Pharmacol 11 (2020):16.PMID:32140106
- Mar Life Sci Tech 4.3 (2022):373-383.PMID:37073164
- Mol Med 31.1 (2025):258.PMID:40681992
- Phytother Res (2025).PMID:40675558
- Biomolecules 12.9 (2022):1283.PMID:36139122
- Biochem Pharmacol (2023):115632.PMID:37263300
- Chinese Med J-Peking (2023):10-1097.PMID:36939243
- Ecotox Environ Safe 289 (2025):117511.PMID:39662457
- Faseb J 37.5 (2023):e22935.PMID:37086094
- J Agr Food Chem 71.1 (2022):546-556.PMID:36538589
- Neurotoxicol Teratol (2025):107500.PMID:40456500
- J Agr Food Chem (2025).PMID:40899763
- Eur J Pharm Biopharm 188 (2023):89-99.PMID:36702198
- Front Immunol 16 (2025):1591912.PMID:40655141
- J Agr Food Chem 71.3 (2023):1593-1606.PMID:36634077
- Bone Joint Res 13.12 (2024):763.PMID:39662502
- Glia (2024).PMID:39610064
- Molecules 28.6 (2023):2426.PMID:36985397
- J Oncol 2022 (2022):6459029PMID:36199788
- Biochem Pharmacol (2024):116688.PMID:39617210
- Transl Oncol 52 (2025):102256.PMID:39733744
- J Ethnopharmacol (2024):119272.PMID:39716512
- Molecules 27.21 (2022):7183.PMID:36364008
- Cell Cycle 21.3 (2022):228-246.PMID:34965191
- Front Endocrinol 13 (2022):998971.PMID:36147560
- Cell Cycle 21.8 (2022):835-850.PMID:35100080
- J Oncol 2022 (2022).PMID:36213838
- J Ethnopharmacol 307 (2023):116193.PMID:36746295
- J Dermatol Sci 109.2 (2023):52-60.PMID:36858850
- Nutrients 17.5 (2025):923.PMID:40077793
- Invest Ophth Vis Sci 66.1 (2025):24-24.PMID:39792075
- Int Immunopharmacol 147 (2025):113871.PMID:39798467
- Mol Neurobiol 59.8 (2022):4776-4790.PMID:35622272
- Bioengineering 9.9 (2022):433.PMID:36134979
- Radiother Oncol (2024):110686.PMID:39709027
- Front Oncol 12 (2022):996080.PMID:36483054
- Acs Infect Dis 8.9 (2022):1851-1868.PMID:35948057
- Drug Deliv Transl Re (2023):1-13.PMID:37130996
- Molecules 27.23 (2022):8568.PMID:36500666
- Cell Death Discov 8.1 (2022):85.PMID:35220396
- Front Oncol 12 (2022):1043161.PMID:36439418
- J Virol (2023):e00549-23.PMID:37222617
- J Dent (2024):105436.PMID:39488296
- Int Immunopharmacol 138 (2024):112533.PMID:38924868
- Life Sci (2024):123148.PMID:39447733
- Front Endocrinol 13 (2022):657802.PMID:36263320
- Front Oncol 12 (2022):961653.PMID:36457504
- Bone Joint Res 13.12 (2024):763-777.PMID:39662502
- J Cell Mol Med 26.13 (2022):3783-3796.PMID:35656815
- Molecules 27.14 (2022):4603.PMID:35889477
- Invest Ophth Vis Sci 63.6 (2022):13-13.PMID:35695808
- Bioorg Chem 136 (2023):106556.PMID:37105002
- Drug Des Dev Ther (2025):281-302.PMID:39845152
- J Agr Food Res (2025):101694.
- Commun Biol 8.1 (2025):71.PMID:39820362
- J Drug Deliv Sci Tec 104 (2025) 106577.
- Radiother Oncol 203 (2025):110686.PMID:39709027
- Colloid Surface B (2025):114537.PMID:39879672
- J Oncol 2022 (2022).PMID:36213831
- J Neurochem 164.5 (2023):643-657.PMID:36527420
- Molecules 27.17 (2022):5698.PMID:36080465
- J Ethnopharmacol (2023):116731.PMID:37277084
- Sci Rep-Uk 13.1 (2023):361.PMID:36611103
- Toxicology (2024):154018.PMID:39608440
- Int Immunopharmacol 107 (2022):108695.PMID:35305385
- Pharmaceuticals 15.11 (2022):1435.PMID:36422564
- J-Ethnopharmacol (2023):116729.PMID:37277081
- Pharmaceuticals 15.10 (2022):1271.PMID:36297383
- Microorganisms 11.5 (2023):1268.PMID:37317242
- J Dent (2024):105436.PMID:39488296
- Int Immunopharmacol 108 (2022):108742.PMID:35378447
- J Hepatocell Carcino (2023):863-881.PMID:37313303
- J Oncol 2022 (2022).PMID:36281290
- J Ethnopharmacol 310 (2023):116375.PMID:36934787
- J oncol 2022 (2022).PMID:36385962
- J Ethnopharmacol (2024):119073.PMID:39522846
- Mol Carcinogen 62.2 (2023):160-173.PMID:36222184
- Environ Toxico (2024).PMID:38700384
- Int J Mol Med 52.5 (2023):1-14.PMID:37800609
- Int Immunopharmacol 138 (2024):112559.PMID:38955028
- Mol Neurobiol (2024):1-18.PMID:38995443
- Cns Neurosci Ther 31.5 (2025):e70437.PMID:40400263
- Eur J Pharmacol 998 (2025):177497.PMID:40058753
- Clin Immunol (2024):110308.PMID:39002794
- Int J Mol Sci 26.13 (2025):5999.
- Diabetol Metab Syndr 16.1 (2024):1-14.PMID:38317244
- Drug Des. Dev. Ther. (2025):5123-5141.PMID:40546656
- Biotechnol J 19.1 (2024):2300453.PMID:37899497
- Mol Nutr Food Res (2024):2300912.PMID:38847553
- Am J Cancer Res 14.1 (2024):324.PMID:38323285
- Int Immunopharmacol 138 (2024):112625.PMID:38996666
- J Ethnopharmacol (2024):118080.PMID:38521426
- Int J Mol Sci 26.10 (2025):4953.PMID:40430095
- Am J Physiol-Cell Ph (2024).PMID:39069827
- Biochem Pharmacol (2024):116438.PMID:39025409
- Front Toxicol 7 (2025):1598185.PMID:40376450
- J Drug Deliv Sci Tec 107 (2025):106841.
- J Ethnopharmacol 347 (2025).PMID:40187623
- Food Funct. (2025).
- J Cell Mol Med 24.7 (2020):4136-4149.PMID:32100443
- Aging (Albany NY) 16.8 (2024):6773.PMID:38643468
- Bioorg Chem (2025):108926.PMID:40907438
- Int Immunopharmacol 138 (2024):112539.PMID:38936054
- Pharmaceuticals-Base 18.8 (2025):1187.
- Int Immunopharmacol 159 (2025):114886.PMID:40424656
- Chem-Biol Interact 382 (2023):110638.PMID:37473910
- Acs Biomater Sci Eng (2024).PMID:39164198
- Arch Toxicol (2025):1-17.PMID:40464975
- Drug Des Dev Ther (2025):5123-5141.
- J Ethnopharmacol (2025):120157.PMID:40532799
- Transl Oncol 47 (2024):102042.PMID:38924847
- J Cell Mol Med 28.6 (2024):e18223.PMID:38451046
- Arch Toxicol (2024):1-16.PMID:38971901
- Eur J Pharmacol (2025):178123.PMID:40914268
- Cell Cycle 19.17 (2020):2139-2147.PMID:32779548
- Burns Trauma 12 (2024):tkae001.PMID:38434722
- Bioorg Chem (2025):108667.
- PLoS Pathog. 21.9 (2025):e1013492.PMID:40920846
- Bioorg Chem (2025):108656.
- Journal of the American Heart Association 14.16 (2025):e040093.PMID:40767292
- Front. Pharmacol. 16 (2025):1613560.PMID:40822457
- Antivir Ther 30.3 (2025):13596535251345953.PMID:40434182
- Transactions of Nonferrous Metals Society of China 35.8 (2025):2726-2733.
- J Ethnopharmacol (2024):117985.PMID:38417600
- J Ethnopharmacol (2024):117958.PMID:38395179
- Int Immunopharmacol 138 (2024):112533.PMID:38924868
- Virulence 16.1 (2025):2500493.PMID:40521898
- Food Funct (2025).PMID:40421817
- Int J Mol Sci 26.10 (2025):4953.PMID:40430095
- Int Immunopharmacol 165 (2025):115441.PMID:40911993
- Mol Neurobiol (2025):1-16.PMID:40402409
- J Ethnopharmacol (2024):117865.PMID:38369066
- J Ethnopharmacol (2024):118685.PMID:39127116
- Macromol Biosci (2024):2400003.PMID:38597147
- Antimicrob Agents Ch 65.6 (2021):10-1128.PMID:33753340
- Food Biosci (2025):106564.
- Faseb J 38.7 (2024):e23591.PMID:38572579
- Environ Toxicol (2023).PMID:38069587
- Transl Oncol 56 (2025):102396.PMID:40239242
- Glia (2025).PMID:40747821
- Eur-J Pharmacol 958 (2023):176033.PMID:37673365
- Cell Signal (2023):110987.PMID:38029946
- Redox Rep 29.1 (2024):2398380.PMID:39284588
- Macromol Biosci (2024):2400003.PMID:38597147
- J. Drug Delivery Sci. Technol. (2025):106841.
- Antimicrob Agents Ch 65.6 (2021):10-1128.PMID:33753340
- J Virol 97.11 (2023):e00719-23.PMID:37929962
- Cell Signal 113 (2024):110962.PMID:37931691
- Exp Neurol (2025):115252.PMID:40221008
- Int Immunopharmacol 163 (2025):115226.PMID:40663811
- Life Sci 254 (2020):117793.PMID:32416164
- Mol Carcinogen (2023).PMID:37750597
- Mol. Nutr. Food Res. (2025):e70053.PMID:40177855
- J. Ethnopharmacol. (2025):119727.PMID:40187623
- Am J Physiol-Gastr L (2024).PMID:38742280
- Acs Appl Bio Mater (2024).PMID:38700956
- Aging (Albany NY) 15.23 (2023):14292.PMID:38059876
- Cell Oncol (2025):1-17.PMID:41051595
- J Am Heart Assoc (2025):e040093.PMID:40767292
- Front Pharmacol 16 (2025):1613560.PMID:40822457
- Chem-Biol Interact (2025):111630.PMID:40609922
- Front Cell Dev Biol 12 (2024):1391873.PMID:39170916
- Chem-Biol Interact (2025):111702.PMID:40812562
- Int. J. Mol. Sci. 26.9 (2025):4325.
- Int Immunopharmacol 141 (2024):112955.PMID:39163685
- J Ethnopharmacol 319 (2024):117205.PMID:37741473
- Aging 16.8 (2024):6773-6795.PMID:38643468
- CANCER CELL INT 25.1 (2025):1-24.PMID:40296031
- J Ethnopharmacol 319 (2024):117091.PMID:37634753
- ACS Appl. Nano Mater. (2025).
- J Nutr Biochem (2024):109780.PMID:39395694
- Int Immunopharmacol 162 (2025):115151.PMID:40609203
- Sci Rep-Uk 13.1 (2023):14339.PMID:37658227
- Rsc Adv 14.18 (2024):12864-12872.PMID:38650686
- Pediatr Res (2024):1-10.PMID:38658662
- Cancer Biol Ther 25.1 (2024):2325126.PMID:38445610
- Bmc Cancer 24.1 (2024):1-16.PMID:38475728
- J Biochem Mol Toxic 38.4 (2024):e23675.PMID:38488158
- Toxicol Sci (2024):kfae054.PMID:38636494
- Heliyon (2024).PMID:38707472
- Neurochem Res (2023):PMID:37127800
- J Inflamm Res (2024):10533-10546.PMID:39659750
- Sci Rep-Uk 14.1 (2024):14438.PMID:38910141
- Bmc Cancer 24.1 (2024):465.PMID:38622522
- Front Oncol 14 (2024):1471109.PMID:39582546
- Cancer Biol Ther 25.1 (2024):2355705.PMID:38778753
- Neuroscience (2023).PMID:37286157
- Front Pharmacol 15 (2024):1453938.PMID:39654626
- Acta Derm-Venereol 104 (2024).PMID:38590175
- Brain Res Bull (2024):111165.PMID:39667505
- Bmc Complement Med 24.1 (2024):1-16.PMID:38580999
- Gene (2024):148399.PMID:38518902
- J Immunother (2024):10-1097.PMID:38847148
- Bmc Complement Med 24 (2024).PMID:38783288
- Bioscience Rep 43.5 (2023):BSR20230028.PMID:37083601
- Metabolomics 20.5 (2024):112.PMID:39369160
- J Biochem Mol Toxic 38.1 (2024):e23544.PMID:37815058
- Ann Transl Med 10.24 (2022).PMID:36660714
- Gene (2023):148050.PMID:38042211
- Oral Dis (2024).PMID:38168877
- Sci Rep-Uk 14.1 (2024):18929.PMID:39147857
- Eur J Pharmacol 983 (2024):176995.PMID:39277096
- J Neuro Oncol (2023):1-16.PMID:37351767
- Sci Rep-Uk 14.1 (2024):19292.PMID:39164313
- Zool Res 45.5 (2024).PMID:39147715
- Toxicol Appl Pharm (2023):116794.PMID:38142782
- Mol Cell Biochem (2024):1-15.PMID:39179754
- Environ Toxicol (2024).PMID:39400944
- Toxicol Lett 379 (2023):20-34.PMID:36905973
- Front Pharmacol 15 (2024):1424624.PMID:25956975
- Bba-Mol Basis Dis (2024):167467.PMID:39159699
- J Steroid Biochem (2023):106429.PMID:38035949
- Bmc Chem 18.1 (2024):1-11.PMID:39396055
- Biomed Mater 18.6 (2023):065026.PMID:37852221
- Eur J Pharmacol (2024):176995.PMID:39277096
- Langmuir 39.39 (2023):14162-14172.PMID:37722015
- Rsc Adv 13.33 (2023):23010-23020.PMID:37529353
- Sci Rep-Uk 14.1 (2024):21680.PMID:39289451
- Epigenetics-Us 18.1 (2023):2254976.PMID:37691391
- Rsc Adv 13.32 (2023):22367-22374.PMID:37497090
- Mol Cells 46.4 (2023):231-244.PMID:36625319
- Gerontology (2024).PMID:38168028
- Heliyon 8.11 (2022).PMID:36353164
- Sci Rep-Uk 14.1 (2024):27063.PMID:39511266
- Bioorgan Med Chem 82 (2023):117234.PMID:36906964
- J Inflamm Res (2024):8009-8026.PMID:39507268
- J Biol Chem (2024):107499.PMID:38944125
- Microbiol Spectr (2024):e04142-23.PMID:38421191
- J Inflamm Res (2024):8009-8026.PMID:39507268
- Sci Rep-Uk 14.1 (2024):25636.PMID:39465338
- Bmc Genomics 25.1 (2024):1-13.PMID:38395755
- Bba-Mol Basis Dis (2024):167354.PMID:39004378
- J Pharmacol Exp Ther 388.3 (2024):827-845.PMID:38262745
- Bioorgan Med Chem 72 (2022):116994.PMID:36087428
- J Cancer 15.5 (2024):1397.PMID:38356722
- Endocrine (2024):1-14.PMID:38378893
- Aging (Albany NY) 16.14 (2024):11339.PMID:39029955
- J Cell Mol Med 28.20 (2024):e70163.PMID:39462268
- Eur J Pharm Biopharm (2024):114417.PMID:39013493
- Front Genet 13 (2022):932973.PMID:36118847
- Front Genet 13 (2022):959109.PMID:36147489
- Zool Res 45.5 (2024):1001.PMID:39147715
- Cytokine 176 (2024):156507.PMID:38244240
- Endocrine (2024).PMID:38191984
- Front Oncol 14 (2024):1440906.PMID:39346724
- Front Pharmacol 15 (2024):1397761.PMID:39104391
- J Gen Virol 105.1 (2024):001944.PMID:38180473
- Environ Toxicol (2023).PMID:37052456
- Oncol Rep 53.2 (2025):1-9.PMID:39670302
- Biotechnol Genet Eng (2023):1-15PMID:37018431
- Poultry Sci (2025):105339.
- Inflammation 45.1 (2022):372-386.PMID:34792688
- Sci. Rep. 15.1 (2025):15556.PMID:40319036
- Am J Transl Res 13.10 (2021):11255.PMID:34786056
- Bmc Cancer 21.1 (2021):1181.PMID:34740322
- Biol 14.6 (2025):594.
- Oncol Rep 46.6 (2021):1-12.PMID:34643248
- Front Pharmacol 16 (2025):1565713.PMID:40474975
- Front Toxicol 7 (2025):1598185.PMID:40376450
- Transl Oncol 14.12 (2021):101219.PMID:34555726
- Oncotargets Ther (2020):2511-2522.PMID:32280236
- J Inflamm Res (2025):7401-7417.PMID:40503490
- Spectrochim Acta A 237 (2020):118387.PMID:32416513
- Bmc Cancer 21.1 (2021):1-15.PMID:34130645
- Acs Omega (2025).
- Probiotics Antimicro (2025):1-16.PMID:40366615
- J. Funct. Foods 128 (2025):106822.PMID:39486993
- Biomedicines 13.6 (2025):1315.PMID:40564034
- Sci Rep-Uk 15.1 (2025):11639.PMID:40185911
- Hum Cell 35.4 (2022):1140-1158.PMID:35581525
- J Oncol 2022 (2022).PMID:35518787
- Bmc Cancer 22.1 (2022):1-14.PMID:35387643
- Front Pharmacol 16 (2025):1517221.
- Front Pharmacol 16 (2025):1562839.PMID:40183104
- Frontiers in Pharmacology 16 (2025):1547685.
- Cell Death Dis 16.1 (2025):287.PMID:40223081
- J. Cell. Mol. Med. 29.8 (2025):e70476.PMID:40275529
- Cell Signal (2025):111815.PMID:40258578
- Int J Mol Med 49.3 (2022):1-11.PMID:35014672
- Thorac Cancer 13.5 (2022):761-770.PMID:35098684
- Sci Rep-Uk 15.1 (2025):13282.PMID:40247060
- Food Chem. Toxicol. (2025):115488.PMID:40288513
- Hypertens Res 45.4 (2022):650-664.PMID:35082376
- Front. Oncol. 15 (2025):1536473.PMID:40303992
- Ann Med 57.1 (2025):2523563.PMID:40579858
- J Ethnopharmacol 259 (2020):112956.PMID:32442587
- Front. Pharmacol. 16 (2025):1545498.
- Ann Surg Oncol (2025):1-20.PMID:40887570
- J Virol 99.8 (2025):e00498-25.PMID:40631894
- Toxicol Appl Pharm 410 (2021):115361.PMID:33285147
- Sci Rep-Uk 10.1 (2020):20623.PMID:33244088
- Oncol Res 33.8 (2025):2085.PMID:40746890
- Pestic Biochem Phys (2025):106728.
- Poultry Sci (2025):105818.
- Mol Med Rep 31.5 (2025):138.PMID:40145553
- Bba-Mol Basis Dis (2025):168050.PMID:40946874
- Faseb J39.7 (2025):e70530.PMID:40193045
- Faseb J 39.16 (2025):e70961.PMID:40827901
- J Mech Behav Biomed 167 (2025):106963.PMID:40120143
- Oncotargets Ther (2020):11301-11313.PMID:33177838
- Sci Rep-Uk 15.1 (2025):18697.PMID:40436970
- Poultry Sci (2025):105339.PMID:40482626
- Microb Pathogenesis (2025):107720.PMID:40403987
- Exp Cell Res (2025):114674.PMID:40683587
- ACS Omega (2025).PMID:40686969
- J Ethnopharmacol 278 (2021):114275.PMID:34087404
- Sci Rep-Uk 15.1 (2025):26300.PMID:40683918
- Oncol Rep 46.1 (2021):1-12.PMID:34080652
- Probiotics Antimicro (2025):1-16.PMID:40366615
- Iscience 28.7 (2025).
- Sci Rep-Uk 15.1 (2025):24303.PMID:40624204
- Sci Rep-Uk 15.1 (2025):25039.PMID:40646181
- Exp Cell Res (2025):114674.PMID:40683587
- Sci Rep-Uk 15.1 (2025):27517.PMID:40721473
- Sci Rep-Uk 15.1 (2025):30446.PMID:40830225
- Toxicol Appl Pharm 422 (2021):115559.PMID:33961903
- Acta Diabetol 58.9 (2021):1251-1267.PMID:33907874
- Bmc Genomics 26.1 (2025):706.PMID:40745632
- J Ovarian Res 18 (2025):168.PMID:40731365
- Mol Neurobiol (2025):1-20.PMID:40742404
- Oncol Res 33.8 (2025):2085.PMID:40746890
- Biology 14.9 (2025)
- J Biomed Mater Res A 113.3 (2025):e37893.PMID:40059713
- Food Chem Toxicol (2025):115488.PMID:40288513
- Brain Res Bull 187 (2022):1-10.PMID:35738501
- Mol Cell Biochem (2025):1-20.PMID:40032749
- Arch Biochem Biophys (2025):110352.PMID:39978618
- J Biochem Mol Toxice 36.11 (2022):e23200.PMID:35997646
- Molecules 30.3 (2025):549.PMID:39942654
- Brain Res Bull (2025):111245.PMID:39924054
- J Cancer 11.5 (2020):1162.PMID:31956362
- Sci Rep-Uk 15.1 (2025):794.
- Arthritis Res Ther 27.1 (2025):12.PMID:39838477
- J Endocrinol Invest (2025):1-16.PMID:39786708
- Front Pharmacol 16 (2025):1536091.PMID:40041493
- Mol Immunol 152 (2022):27-34.PMID:36244215
- Bmc Med Genomics 15.1 (2022):1-19.PMID:36503492
- Pharm Biol 60.1 (2022):1436-1448.PMID:35938494
- Neurotox Res 40.6 (2022):1895-1901.PMID:36223054
- Mol Immunol 153 (2023):126-134.PMID:36495817
- Eur J Pharmacol (2025):177343.PMID:39900330
- Eur J Pharmacol (2025):177497.PMID:40058753
- Oncol Rep 53.2 (2025):1-9.PMID:39670302
- Biotechnol Genet Eng (2023):1-17.PMID:36946780
- Metab Brain Dis 38.1 (2023):255-267.PMID:36445630
- Front Pharmacol 15 (2025):1534772.PMID:39911826
- Mol Cell Biochem (2023):1-11.PMID:36939994
- Faseb J 39.2 (2025):e70314.PMID:39825721
- Metab Brain Dis 37.7 (2022):2349-2362.PMID:35779150
- CURR DRUG DELIV (2025).PMID:39976030
- Bba-Gen Subjects (2024):130628.PMID:38642815
- Future Microbiol 0 (2024).PMID:38629914
- Bmc Cancer 25.1 (2025):1205.PMID:40707929
- Shock (2023):10-1097.PMID:37988072
- Bba-Mol Cell Biol L 1870.5 (2025):159631.PMID:40379088
- Int J Chronic Obstr (2023):919-932.PMID:37229441
- Transbound Emerg Dis 2025.1 (2025).PMID:40692872
- Cell Stress Chaperon 25 (2020):955-968.PMID:32572784
- Pathogens 14.2 (2025):182.
- Microvasc Res (2025):104833.PMID:40571189
- J Orthop Surg Res 19.1 (2024):709.PMID:39487541
- Acta Bioch Bioph Sin 56.10 (2024):1473.PMID:38826133
- Clin Exp Pharmacol P 50.11 (2023):903-913.PMID:37635387
- Cancer Res Commun (2025).PMID:40601866
- Front Mater 12 (2025):1568591.
- Mol Biotechnol (2024):1-15.PMID:38771419
- J Mol Histol (2024):1-8.PMID:38758519
- Funct Integr Genomic 25.1 (2025):1-17.PMID:40608130
- Dis Markers 2022 (2022).PMID:35968506
- Toxicol Appl Pharm (2025):117264.PMID:39952301
- J Orthop Surg Res 18.1 (2023):910.PMID:38031136
- Oncol Res 32.6 (2024):1129.PMID:38827325
- J Orthop Surg Res 19.1 (2024):709.PMID:39487541
- Acta Bioch Bioph Sin 56.10 (2024):1473.PMID:38826133
- J Cancer 16.10 (2025):3048-3064.
- Cell Biochem Funct 43.7 (2025):e70097.PMID:40574709
- Mol Biol Rep 52.1 (2025):212.PMID:39921807
- Toxicology Letters (2025).PMID:40854414
- Luminescence 40.2 (2025):e70116.PMID:39914999
- Molecular brain 18.1 (2025):1-23.PMID:39962509
- RENAL FAILURE 47.1 (2025):2552913.PMID:40898827
- Plos One 19.12 (2024):e0316362.PMID:39724098
- Brain Res (2025):149942.PMID:40930451
- Luminescence 39.1 (2024):e4671.PMID:38286599
- J Mol Neurosci 74.1 (2024):30.PMID:38478195
- Pharmacology 108.2 (2023):166-175.PMID:36724745
- Aesthet Plast Surg (2025):1-15.PMID:40180642
- Heliyon (2024):.PMID:37461802
- Renal Failure 47.1 (2025):2548613.PMID:40887103
- Cell Transplant 33 (2024).PMID:38334047
- S Afr J Bot 177 (2025):445-456.
- Int J Chronic Obstr (2025):623-639.PMID:40092321
- Arch Biochem Biophys 766 (2025):110352.PMID:39978618
- Technol Cancer Res T 19 (2020).PMID:33111613
- Curr Issues Mol Biol 47.5 (2025):314.PMID:40699713
- J Orthop Surg Res 20.1 (2025):443.PMID:40319252
- Chem Biodivers (2025):e00918.PMID:40991575
- Curr Stem Cell Res T 19.7 (2024):1021-1028.PMID:37861049
- N-S Arch Pharmacol (2024):1-21.PMID:39549064
- J Pharm Pharmacol 71.9 (2019):1412-1420.PMID:31282010
- Plos One 20.8 (2025):e0329272.PMID:40758730
- Mol Carcinogen (2025).PMID:40794014
- Mol Cell Biochem 473 (2020):179-192.PMID:32627113
- Bmc Oral Health 24 (2024):1421.PMID:39574093
- Exp Eye Res (2025):110492.
- Biomarkers (2024):1-12.PMID:38568742
- Andrology-Us (2025).PMID:40862537
- N S Arch Pharmacol (2023):1-13.PMID:37160483
- Bmc Pregnancy Childb 25.1 (2025):1001.PMID:41034826
- Exp Eye Res (2025):110492.PMID:40541914
- Mol Cell Biochem 476 (2021):1387-1400.PMID:33389498
- Tissue Cell 80 (2023):102001.PMID:36565506
- Toxicol-Lett-(2025).PMID:40854414
- Eur Rev Med Pharmaco 23.5 (2019).PMID:30915737
- Thorac Cancer 14.9 (2023):815-826.PMID:36737402
- Pathol Res Pract (2025):156247.PMID:41045764
- J Pharm Pharmacol (2025):rgaf094.PMID:41042989
- J Tradit Chin Med 43.4 (2023):744.PMID:37454259
- Mol Med Rep 28.5 (2023):1-12.PMID:37732544
- Front Med-Lausanne 11 (2025):1534120.PMID:39882536
- Shock (2023):10-1097.PMID:37179246
- Hum Mol Genet (2024):ddae122.PMID:39216871
- Gene 932 (2025):148898.PMID:39209182
- FEBS Open Bio 12.1 (2022):146-153.PMID:34644456
- Toxicon (2025):108293.PMID:39999927
- Pathogens 14.2 (2025):182.
- CURR ISSUES MOL BIOL 47.5 (2025):314.
- Mol Brain 18.1 (2025):1-23.PMID:39962509
- J Mol Neurosci 72.2 (2022):433-440.PMID:35023001
- Chem Biol Drug Des 105.4 (2025):e70111.PMID:40247760
- Luminescence 40.2 (2025):e70095.PMID:39924164
- Bioengineered 13.1 (2022):455-468.PMID:34967265
- METABOLITES 15.5 (2025):290.
- Bioengineered 13.1 (2022):1518-1529.PMID:34986734
- Biochem Bioph Res Co (2025):151972.
- Acta Bioch Bioph Sin 56.5 (2024):776.PMID:38495003
- Microb Pathogenesis (2024):107055.PMID:39442820
- Chem Biol Drug Des 99.6 (2022):828-838.PMID:35184389
- Bioengineered 13.3 (2022):6650-6664.PMID:35230214
- Mol Biol Rep 51.1 (2024):1-13.PMID:39422836
- Tissue Cell (2025): 102903.
- Mol Biotechnol 64.12 (2022):1367-1375.PMID:35639278
- Int J Chronic Obstr (2025):623-639.
- Bioengineered 13.5 (2022):11987-12002.PMID:35603556
- MED ONCOL 42.4 (2025):1-13.PMID:40072654
- Dis Markers 2022 (2022).PMID:35845132
- WORLD J GASTRO ONCOL 17.3 (2025):102187.PMID:40092949
- Mol. Med. Rep. 31.5 (2025):1-12.PMID:40145553
- Curr Pharm Biotechno 23.8 (2022):1101-1108.PMID:34463226
- Bioengineered 13.3 (2022):6807-6818.PMID:35246020
- Bioengineered 13.4 (2022):10335-10349.PMID:35435110
- J Sci Food Agr (2024).PMID:39394871
- J Mech Behav Biomed (2025):106963.
- Cell Mol Biol Lett 24.1 (2019):1-14.PMID:31889958
- ONCOL LETT 29.6 (2025):1-12
- Virus Res 313 (2022):198748.PMID:35304133
- Clinics 77 (2022).PMID:35662010
- Mol Carcinogen (2025).PMID:40222040
- Bioengineered 12.2 (2021):11451-11460.PMID:34895055
- Dis Markers 2022 (2022).PMID:35845132
- Bmc Cancer 24.1 (2024):1-21.PMID:39085784
- Toxicol Appl Pharm (2025):117232.PMID:39832565
- Mol Med Rep 31.3 (2025):1-10.
- Discov Oncol 15.1 (2024):280.PMID:39004679
- J Appl Toxicol 42.5 (2022):830-840.PMID:34708435
- Bioengineered 12.1 (2021):8698-8708.PMID:34697986
- Eur J Med Res 30.1 (2025):54.PMID:39865289
- Toxicol Lett (2025).PMID:40412772
- J Integr Complement (2025).PMID:40459144
- Microb Pathogenesis (2025):107720.PMID:40403987
- Genomics (2025):111009.PMID:39864635
- Plos One 20.6 (2025):e0317930.PMID:40455747
- Bioengineered 12.1 (2021):5985-5995.PMID:34477479
- Bioengineered 12.1 (2021):6687-6702.PMID:34516362
- Carcinogenesis (2025):bgaf030.
- Comput Biol Chem (2025):108540.PMID:40483799
- Bosn J Basic Med Sci 20.3 (2020):357.PMID:31733641
- Discov Oncol 15.1 (2024):309.PMID:39060620
- Shock 59.3 (2023):426-433.PMID:36609531
- Integr Cancer Ther 24 (2025).PMID:40944546
- Chem Biol Drug Des 104.1 (2024):e14580.PMID:39031936
- J ORTHOP SURG RES 20.1 (2025):443.PMID:40319252
- Tissue Cell (2024):102477.PMID:39018712
- Planta Med 89.05 (2023):493-507.PMID:35716667
- Bioengineered 12.2 (2021):11936-11946.PMID:34784841
- Kaohsiung J Med Sci (2025):e70031.PMID:40387410
- Curr Cancer Drug Tar 24.9 (2024):975-986.PMID:38204265
- AESTHET PLAST SURG (2025):1-15.PMID:40180642
- Peerj 13 (2025):e19550.PMID:40611940
- Curr Mol Pharmacol 17.1 (2024).PMID:36946474
- Cell Mol Biol 70.2 (2024):161-168.PMID:38430026
- J Obstet Gynaecol Re PMID:39169658
- Andrologia 2025.1 (2025):4092625.
- Transl Cancer Res 14.5 (2025):2594.PMID:40530117
- Pediatr Surg Int 40.1 (2024):63.PMID:38431920
- Chin J Integr Med (2024):1-11.PMID:38941045
- Fitoterapia (2024):106245.PMID:39393711
- TRANSL ANDROL UROL 14.2 (2025).PMID:40114844
- Translational Cancer Research 14.8 (2025).PMID:40950680
- PeerJ 13 (2025):e19083.
- J Interf Cytok Res (2025).PMID:40512525
- Immunobiology (2025):153090.
- J Int Med Res 48.4 (2020).PMID:31891283
- Women's Health Reports 6.1 (2025):803-815.
- Vet Microbiol (2025):110495.
- Immunobiology (2024):152832.PMID:38943814
- Bmc Pediatr 25.1 (2025):42.PMID:39825267
- Mol Cell Probe (2025):102031.
- Cancer Biomark 42.5 (2025):18758592241306263.
- Exp Ther Med 20.4 (2020):3290-3300.PMID:32855700
- Balk Med J 41.6 (2024):491.PMID:39319820
- Vet Parasitol (2024):110284.PMID:39126893
- J Obstet Gynaecol Re PMID:39169658
- J Integr Complement (2025).PMID:40459144
- Hematology 30.1 (2025):2523082.PMID:40611540
- EXP LUNG RES 51.1 (2025):79-92.PMID:40889519
- Biochem Bioph Res Co (2025):152196.PMID:40516308
- J Membrane Biol 253 (2020):43-55.PMID:31820013
- Particul Sci Technol (2025):1-13.
- Oncol Res 33.1 (2024):103.PMID:39735676
- World J Oncol (2024):.
- Transplant Direct 11.7 (2025):e1829.PMID:40590007
- Balk Med J 41.6 (2024).PMID:39319820
- Open Life Sci. 20.1 (2025):20221056.
- Vet Parasitol 331 (2024):110284.PMID:39126893
- Chin J Integr Med (2025):1-10.PMID:40338446
- Comb Chem High T Scr (2024).PMID:35894460
- Biochem Bioph Res Co (2025):152196.PMID:40516308
- N S Arch Pharmacol (2023):1-13.PMID:37052642
- Peerj 13 (2025):e19550.PMID:40611940
- Biochem Bioph Res Co (2025):152500.PMID:40858065
- Genes Genom (2023):1-15.PMID:37318704
- Cell J 24.1 (2022):15.PMID:35182060
- Discov Oncol 14.1 (2023):1-10.PMID:37907650
- Asian J Urol (2025).
- Endocr Metab Immune 24.1 (2024):153-162.PMID:37150983
- Am J Transl Res 15.7 (2023):4873.PMID:37560235
- Chem Biodivers 18.4 (2021):e2001007.PMID:33624427
- Cell J 25.8 (2023):554.PMID:37641417
- Aesthet Plast Surg (2023):1-11.PMID:38148357
- Hematology 28.1 (2023):2220522.PMID:37272581
- Clin Cosmet Inv Dent (2022):87-94.PMID:35411190
- J Int Med Res 48.4 (2020).PMID:31891283
- Cell Mol Biol 69.12 (2023):223-231.PMID:38063090
- J Int Med Res 49.3 (2021).PMID:33730930
- Clin Cosmet Inv Dent (2022):87-94.PMID:35411190
- Cell J 24.1 (2022):15.PMID:35182060
- Ann Hepatol 27.4 (2022):100700.PMID:35338010
- Int J Gen Med (2022):3199-3213.PMID:35342302
- J Toxicol Sci 48.8 (2023):469-479.PMID:37532580
- Int J Gen Med (2022):3199-3213.PMID:35342302
- Clin Hemorheol Micro (2023):1-15.PMID:37212088
- Adv Clin Exp Med 30.10 (2021):1031-1041.PMID:34329545
- Chem Biodivers 18.4 (2021):e2001007.PMID:33624427
- Anim Biotechnol (2023):1-12.PMID:36756956
- Pathol Res Pract 217 (2021):153284.PMID:33249400
- Anticancer Res 43.8 (2023):3411-3418.PMID:37500147
- J Asian Nat Prod Res 24.11 (2022):1078-1085.PMID:34935551
- Neuroreport 33.10 (2022):413.PMID:35623086
- J Cardiothorac Surg 18.1 (2023):222.PMID:37420297
- Am J Transl Res 14.10 (2022):6964.PMID:36398260
- Pediatr Surg Int 39.1 (2022):54.PMID:36534156
- Acta Histochem 125.8 (2023):152097.PMID:37813066
- Toxicon 257 (2025):108293.PMID:39999927
- Oncol Lett 29.6 (2025):276.PMID:40247989
- Bmc Nephrol 24.1 (2023):314.PMID:37884904
- Biochem Genet (2023):1-18.PMID:37148331
- J Craniofac Surg 33.4 (2022):1250-1254.PMID:36041089
- Crit Rev Eukar Gene (2025).
- J Cardiothorac Surg 20.1 (2025):53.PMID:39794868
- Iran J Immunol (2023).PMID:37865874
- J Cardiothorac Surg 20 (2025):270.PMID:40555993
- Jove-J Vis Exp 220 (2025):e68581.
- Transpl P 52.1 (2020):398-405.PMID:31928781
- Transl Cancer Res 13.4 (2024).PMID:38737693
- J Herbs Spices Med P (2025):1-16.
- Int J Biol Sci 20.12 (2024):4713-4730.
- J Nutr Biochem (2024):109769.PMID:9276944
- Int J Mol Sci 25.19 (2024):10339.
- Clin Transl Disc 2.2 (2022):e49.
- Front Pharmacol 13 (2022):899775.PMID:35571096
- Cell Biomaterials (2025):
- Int J Mol Sci 25.19 (2024):10496.
- Phytomedicine (2024):156091.
- Bioengineered 13.4 (2022):9145-9155.PMID:35363601
- Chem Eng J (2024):156542.
- Drug Dev Res 81.4 (2020):437-443.PMID:31904108
- Mater Express 10.1 (2020):102-111.
- Int J Mol Sci 23.8 (2022):4128.PMID:35456945
- Pharmaceuticals-Base 17.10 (2024):1295.
- J Cancer 13.6 (2022):1808.PMID:35399733
- J Transl Med 22.1 (2024):1-16.
- Front Cell Infect Mi 12 (2022):423.PMID:35573770
- New J Chem (2024).
- Nanophotonics 11.22 (2022):5089-5100.
- Front Microbiol 14 (2023).PMID:37645224
- Viruses 16.8 (2024):1239.
- Small (2024):2402308.PMID:3911
- Acs Appl Mater Inter (2024).PMID:39167710
- Aging (Albany NY) 15.12 (2023):5713PMID:37390121
- Exp Ther Med 23.2 (2022):1-9.PMID:35069838
- Exp Ther Med 23.2 (2022):1-9.PMID:35069839
- Bio-Des Manuf 5.2 (2022):358-370.
- ACS omega 8.30 (2023):27146-27155.PMID:37546678
- Plos Pathog 19.4 (2023):e1011305.PMID:37053288
- Bioorg Chem (2024):107731.
- Phytochem Lett 47 (2022):174-179.
- Transl Cancer Res 11.1 (2022):206.PMID:35261897
- Iscience 26.9 (2023).PMID:37670789
- ACS Appl. Eng. Mater. (2025).
- Biomed Pharmacother 179 (2024):117370.
- Bioact Mater 43 (2025):32-47.
- J Hazard Mater (2024) 135735.
- Oncol Lett 23.5 (2022):1-8.PMID:35350588
- Mater Res Express 7.2 (2020):025401.
- J Integr Med-Jim (2024).
- Front Pharmacol 15 (2024):1384141@0.jpg
- Front Oncol 12 (2022):851300.PMID:35392243
- Bba-Mol Cell Biol L 1867.6 (2022):159137.PMID:35247568
- Front Mar Sci 9 (2022):861117.
- Tissue Cell 76 (2022).PMID:35182988
- Nano Today 43 (2022):101416.
- Front Bioeng Biotech 12 (2024):1460870.
- Acs Appl Nano Mater (2024).
- Mol Ther Nucl Acids (2020).
- Pharmacol Res 177 (2022):106112.PMID:35122955
- J Transl Med 22.1 (2024) 1-16.
- Acta Trop 232 (2022):106519.PMID:35584779
- scienceasia (2024).
- Cytotechnology 74.3 (2022):421-432.PMID:35733701
- Adv Funct Mater 29.50 (2019):1906690.
- Adv Funct Mater (2023):2214998.
- Drug Develop Res 84.2 (2023):312-325.PMID:36658741
- Aquaculture 564 (2023):739060.
- Exp Ther Med 25.2 (2023):1-10.PMID:PMID_36684652
- Int J Mol Sci 24.2 (2023):1243.PMID:36674761
- Mater Today Chem 27 (2023):101331.
- Biomedicines 12.11 (2024):2543.
- Heliyon (2024).
- Acs Appl Bio Mater 6.1 (2023):74-82.PMID:36603189
- Histol Histopathol 35.9 (2020):919-927.PMID:32282924
- New J Chem 48.11 (2024):5068-5073.
- bioRxiv (2025):2025-01.
- Mol Cell Toxicol (2022):1-11.
- Cells 11.22 (2022):3580.PMID:36429010
- Oncol Lett 26.1 (2023):1-17.
- Colloid Surface B 228 (2023):113364.PMID:37290201
- J Agr Food Chem 70.44 (2022):14220-14234.PMID:36300841
- Int J Pept Res Ther 29.2 (2023):19.
- View-China 4.2 (2023):20220052.
- J Inflamm Res (2023):1045-1057.PMID:36936349
- J Funct Foods 123 (2024):106621.
- Int J Mol Sci 24.7 (2023):6279.PMID:37047251
- bioRxiv (2023):2023-05.PMID:37292976
- Drug Des Dev Ther (2024):5841-5851.
- Oxid Med Cell Longev 2023 (2023).PMID:36778205
- Sensor Actuat B-Chem 381 (2023):133437.
- Mol Med 29.1 (2023):6.PMID:36647009
- Front Pharmacol 15:1453938.
- Faseb J 38.15 (2024):e23876.
- Poultry Sci 102.4 (2023):102511.PMID:36805396
- Curr Issues Mol Biol 45.5 (2023):4017-4034.PMID:37232725
- J Thorac Dis 15.4 (2023):2198.PMID:37197522
- Ceram Int 49.15 (2023):25953-25963.
- Cancer Res Commun 2.6 (2022):471-482.PMID:36338546
- Cancers 14.21 (2022):5218.PMID:36358640
- J Hazard Mater (2024):136113.
- Int J Mol Sci 25.15 (2024):8340.
- Biosens Bioelectron (2024):116875.
- Dis Markers 2022 (2022).
- Bioact Mater 44 (2025):220-235.
- Oxid Med Cell Longev 2022 (2022).PMID:35936222
- Heliyon (2024).
- J Oncol 2022 (2022).PMID:35909906
- Phytomedicine 105 (2022):154330.PMID:35905566
- Drug Resist Update (2024):101161.
- Carbohyd Polym 295 (2022):119878.PMID:35989018
- Transl Cancer Res 11.6 (2022):1781.PMID:35836521
- Mater Today Adv 15 (2022):100271.
- Oxid Med Cell Longev 2022 (2022).PMID:35770048
- Foods 11.11 (2022):1575.PMID:35681325
- Phytomedicine 103 (2022):154199.PMID:35679793
- Carbohyd Polym (2024):122897.
- bioRxiv (2022):2022-04.
- Biomaterials Advances 142 (2022):213165.PMID:36341744
- Antioxidants 13.11 (2024) 1320.
- Phytother Res 34.4 (2020):836-845.
- Pharmaceutics 14.10 (2022):2157.PMID:36297592
- Gene (2024) 149056.
- Ecotox Environ Safe 286 (2024):117233.
- bioRxiv (2024) 2024-10.
- Antioxidants-Basel 13.11 (2024):1289.
- Acs Appl Polym Mater 4.10 (2022):7014-7024.
- Discov Oncol 13.1 (2022):71.PMID:35941331
- Phytother Res 37.2 (2023):477-489.PMID:36199227
- Cancers 14.19 (2022):4645.PMID:36230568
- Molecules 27.16 (2022):5337.PMID:36014573
- Int J Mol Sci 25.20 (2024):11184.
- J Oncol 2022 (2022).PMID:36059813
- Viruses 14.8 (2022):1783.PMID:36016405
- Int J Mol Sci 23.16 (2022):9014.PMID:36012290
- Appl Entomol Zool 58.4 (2023):303-313.
- J Pharm Anal (2024):101053.
- Nano Today 41 (2021):101326.
- Heliyon (2024).
- Mol Biotechnol 63.8 (2021):686-693.PMID:33977498
- Food Sci Nutr (2023).
- Applied Sciences 14.8 (2024):3186.
- Adv Funct Mater (2024):2402663.
- Phytomedicine 86 (2021):153565.PMID:33945919
- Acs Pharmacol Transl (2024).
- Open Med-Warsaw 16.1 (2021):558-569.PMID:33869778
- Cells 13.9 (2024):728.
- Front Cell Neurosci 15 (2021):569424.PMID:33815059
- Biomaterials 272 (2021):120757.PMID:33798960
- Acs Appl Opt Mater (2024).
- Redox Biol (2024):103143.
- Pharmaceutics (2023) 15(12):2713.
- Nanoscale (2024).
- Biocell 47.8 (2023).
- Ann Hematol (2023):1-12.
- Int J Biol Sci 20.2 (2024):433-445.PMID:37379961
- Vaccines-Basel 11.11 (2023):1678.PMID:38006011
- bioRxiv (2024):2024-05.
- BioRxiv (2025):2025-01.PMID:39975379
- Adv Funct Mater (2024):2400489
- Transl Cancer Res 13.4 (2024).
- Phytomedicine (2024):155656.
- Front Immunol 14 (2023).PMID:37901236
- Acta Pharmacol Sin 44.1 (2023):255-257.PMID:35773339
- Pharmaceuticals-Base 17.4 (2024):515.
- Seoul University Graduate Schoo2025.
- Exp Eye Res 209 (2021):108642.PMID:34058232
- Crit Rev Eukar Gene 34 (2024).
- Acs Appl Bio Mater 4.6 (2021):5026-5032.
- Biol 14.7 (2025):780.PMID:40723340
- Diabet Metab Synd Ob (2021):2255-2268.PMID:34045875
- Compos Part B-Eng 220 (2021):108984.PMID:35988999
- J Agr Food Chem (2024).
- Int J Gen Med (2023):5817-5839.PMID:38106976
- Phytomedicine (2024):155744.
- bioRxiv (2025):2025-08.
- Cell Biomaterials (2025).
- Mater Today Bio (2024):100958.
- bioRxiv (2024):2024-02.
- Mater Design (2024):112812.
- Bladder 12.2 (2025):e21200036.PMID:40747461
- bioRxiv (2025):2025-08.
- J Funct Foods 114 (2024):106076.
- Int J Biol Macromol 307 (2025).PMID:40112979
- Front Immunol 15 (2024):1347683.PMID:38343537
- J Biomed Nanotechnol 20.1 (2024):133-142.
- Front Immunol 15 (2024):1326137.
- J Ethnopharmacol (2024):117867.PMID: 38342155
- Int J Mol Sci 21.21 (2020):8095.PMID:33142980
- Kaohsiung J Med Sci (2024).PMID:38340032
- Cell Death Dis 15.1 (2024):97.PMID:38286802
- J Pharm Sci 75.10 (2020):505-509.PMID:33305726
- Front Cell Dev Biol 8 (2021):568304.PMID:33763412
- Exp Ther Med 27.5 (2024):1-16.
- Biomed Pharmacother 170 (2024):116042.PMID:38118351
- Oncol Rep 51.2 (2024):1-13.PMID:38131250
- New J Chem 48.11 (2024):5068-5073.PMID:PMID
- bioRxiv (2025):2025-08.
- Adv Funct Mater (2023):2309690.
- J Biol Chem 297.2 (2021).PMID:33722608
- Front Pharmacol 11 (2021):618262.PMID:33551818
- Int J Mol Sci 25.2 (2024):919.
- Anal Cell Pathol 2020 (2020).PMID:33354489
- Adv Funct Mater (2024):2305827.
- Fitoterapia (2024):105884.
- Eur J Med Chem (2024):116323.PMID:(2024) 116323.
- Phytomedicine (2024):155347.
- Mol Ther-Nucl Acids (2020).
- Sensors & Diagnostics (2024).
- Am J Chinese Med (2025):1-20.PMID:40646505
- Int J Mol Sci 24.19 (2023):15003.PMID:37834451
- Crystals 13.7 (2023):1067.
- Nano Res (2022):1-8.
- Cell Mol Biol 69.5 (2023):44-50.PMID:37571902
- Chem Eng J 474 (2023):145358.
- Int J Bioprinting (2024).
- Phytochem Lett 46 (2021):79-89.
- Green Process Synth 13.1 (2024):20240050.
- Bioact Mater 36 (2024):524-540.
- Am J Cancer Res (2024):2852-2867.
- Biocell 47.8 (2023).
- Exp Ther Med 26.5 (2023):1-15.PMID:37869642
- Cells 10.9 (2021):2399.PMID:34572049
- Int J Nanomed (2023):5423-5440.PMID:37767196
- Netw Model Anal Hlth 13.1 (2024):1-15.
- J-Ethnopharmacol 318 (2024):116961.PMID:37541404
- Int J Mol Sci 22.16 (2021):8898.PMID:34445601
- J Environ Pathol Tox 42 (2023).PMID:36749091
- Vaccines Basel 11.7 (2023):1190.PMID:37515006
- Dis Markers 2021 (2021):1-12.PMID:34413913
- Acs Omega (2024).
- Tissue Cell 74 (2022):101680.PMID:34808429
- J Tradit Compl Med (2024).
- Indian J Pharm Sci 86.3 (2024).
- Heliyon (2024).
- Int Immunopharmacol 123 (2023):110709.PMID:37515849
- J-Ethnopharmacol 318 (2024):116969.PMID:37516391
- Nutrients 16.14 (2024):2346.
- hLife (2024).
- Nutrients 16.14 (2024):2314.
- Antioxidants Basel 13.3 (2024):264.
- PeerJ 9 (2021):e11482.PMID:34820154
- Toxins 16.7 (2024):319.
- Poultry Sci 102.10 (2023):102946.PMID:37542939
- Rev Bras Farmacogn (2024):1-7.
- Carbohyd Polym 277 (2022):118869.PMID:34893274
- Nanomaterials 11.8 (2021):2008.PMID:34443839
- Microorganisms 11.9 (2023):2258.PMID:37764102
- J Inflamm Res 14 (2021):2445.
- J King Saud Univ Sci 32.7 (2020):2912-2919.
- Trop J Pharm Res 22.9 (2023):1857-1862.
- Oxid Med Cell Longev 2021 (2021):1-30.PMID:34257808
- Phytomedicine (2024):155767.
- Molecular Therapy Oncology (2024).
- J Clean Prod 315 (2021):128201.
- Food Hydrocolloid 120 (2021):106980.
- Mol Cell Toxicol (2023):1-10.
- Pharmaceutics 16.6 (2024):744.
- Theranostics 14.7 (2024):2687.
- Pharmaceuticals-Base 16.10 (2023):1482.PMID:37895953
- Cancer Manag Res (2021):4709-4723.PMID:34163246
- HemaSphere 5.7 (2021).PMID:34136753
- Front Pharmacol 15 (2024):1389976.
- Available at SSRN 4830418.
- Biochip J (2023):1-10.
- Trop J Pharm Res 22.9 (2023):1779-1784.
- BioRxiv (2025):2025-06.
- Biomed Res Int 2021 (2021).PMID:34373837
- Talanta (2024):126381.
- Mol Cell Oncol 10.1 (2023):2238873.PMID:37649964
- BioRxiv (2025):2025-06.
- Fiber Polym (2022):1-9.
- Diss. University of Kansas, 2025.
- Chin Herb Med (2024).
- Acs Omega (2024).
- Mol Cell Biochem (2024) 1-13.
- Front Oncol 10 (2020):387.
- J Cancer 15.13 (2024):4244-4258.
- J Inflamm Res 14 (2021):3523.PMID:34335041
- Nat Commun 15.1 (2024):4969.PMID:38862489
- Int J Mol Sci 24.21 (2023):15545.PMID:37958531
- Appl Entomol Zool (2022):1-14.
- Heliyon (2024).
- Sensor Actuat B Chem 394 (2023):134396.
- Int J Mol Sci 25.24 (2024):13439.
细胞计数试剂盒-8(CCK-8)使用WST-8(2-(2-甲氧基-4-硝基苯基)-3-(4-硝基苯基)-5-(2,4-二磺酚基)-2H-tetrazolium,单钠盐),在存在电子载体1-Methoxy PMS的情况下,产生水溶性福尔马定染料进行方便的测定。 CCK-8溶液直接加入到细胞中,无需预先混合组分。 WST-8被细胞脱氢酶生物还原为可溶于组织培养液的橙色福尔马定产物。 产生的福尔马定量与活着的细胞数量成正比。由于CCK-8溶液非常稳定且具有很小的细胞毒性,因此可以进行更长时间(例如24至48小时)的孵育。
细胞计数试剂盒 - 8允许灵敏度高、用于增殖和毒性测定中确定存活细胞数量的显色法检测。 检测灵敏度比MTT、XTT或MTS等任何其他四唑盐都要高。
图1:Cell Counting Kit-8(CCK-8)的工作机制。
细胞数量确定
1.将细胞悬浮液(100μL/孔)接种在96洞孔板中。将板在潮湿的培养箱中预孵育(例如,在37℃,5%CO2下)。
2.向板的每个孔中加入10μLCCK8溶液。注意不要在孔洞中引入气泡,因为它们会干扰O.D.读数。
3.将培养板在培养箱中孵育1-4小时。
4.使用酶标仪测量450 nm处的吸光度。
细胞增殖和细胞毒性测定
1.将种子细胞以103-104个细胞/孔的密度在96孔板中在100μL培养基中培养。将细胞在CO2培养箱中于37℃培养24小时。
2.将不同浓度的待测物质加入板中。
3.将培养板在培养箱中孵育适当的时间(例如,6,12,24或48小时)。
4.使用重复移液器向板的每个孔中加入10μLCCK8溶液。注意不要在孔洞中引入气泡,因为它们会干扰O.D.读数。
5.将培养板在培养箱中孵育1-4小时。
6.在读取孔板之前,重要的是在轨道振动器上轻轻混合1分钟,以确保颜色均匀分布。
7.使用酶标仪测量450 nm处的吸光度。
数据分析
统计分析有几种方法,您可以选择使用O.D.值或细胞数量,我们提供其中一种方法。
细胞存活率(%)= [(As-Ab)/(Ac-Ab)]×100
抑制率(%)= [(Ac-As)/(Ac-Ab)]×100
As =实验孔吸光度(含有细胞,培养基,CCK-8和待测化合物的孔的吸光度)。
Ab =空白孔吸光度(含有培养基和CCK-8的孔的吸光度)。
Ac =对照孔吸光度(含有细胞,培养基和CCK-8的孔的吸光度)。
制作标准曲线
1. 细胞计数板计数细胞悬液中的细胞数。
2. 使用培养基,等比稀释细胞悬液为一个浓度梯度,通常需要5-7个浓度梯度,每组几个复孔。然后接种细胞。(注意每孔的细胞数量。如果您将细胞悬液稀释在管中,在加入培养板的孔之前,请小心再次混匀细胞。每孔中细胞悬液的体积应该是一致的。)
3. 培养直至细胞贴壁(通常2-4小时),然后每100 μl培养基加入10 μl CCK-8。继续孵育1-4小时,用酶标仪测量450nm处的吸光度。制作出一条以细胞数为X轴坐标,O.D.值为Y轴坐标的标准曲线。
可以基于该曲线确定待测样品的细胞数。使用此标准曲线的先决条件是培养检测条件相同。
注意事项
1. 确保药物和CCK8均匀分布在培养基中。
2. 细胞增殖越多, 颜色越深; 细胞毒性越强,颜色越浅。
3. 对于贴壁细胞,每孔至少需要1000个细胞(100 μl培养基)。对于白细胞,由于灵敏度较低,每孔至少需要2500个细胞(100 μl培养基)。推荐的96孔板每孔最大细胞数为25000。如果使用24孔或6孔板进行该检测,请计算相应的每孔的细胞数,并调整CCK-8的体积,使其为每孔总液体体积的10%。
4. 因为CCK8测定是基于活细胞中的脱氢酶活性,影响脱氢酶活性的条件或化学物质可能导致实际活细胞数与使用CCK-8测定活细胞数之间有差异。
5. WST-8可能与还原剂反应生成WST-8 formazan。如果使用还原剂 (例如一些抗氧化剂)会干扰检测。如果待检测体系中存在较多的还原剂,需设法去除。
6. 孵育2小时后,背景O.D.值一般为0.1-0.2单位。
7. 注意不要在孔中引入气泡,因为它们会干扰O.D.值。
8. 如果您想对CCK8溶液进行灭菌,请使用0.2 μm的膜过滤溶液。
9. 孵育时间因孔中细胞的类型和数量而异。通常,白细胞着色较弱,因此可能需要较长的孵育时间(长达4小时)或大量细胞(~105细胞/孔)。
10. 如果细胞悬液中存在高浊度, 测量并减去样品在600nm或更高波长的O.D值。
11. CCK8不能用于细胞染色。
12. 培养基中的酚红不会影响实验结果,酚红的吸光度可以在计算时,通过扣除空白孔中本底的吸光度而消去,因此不会对检测造成影响。
13. CCK8的毒性非常低,在CCK8测定完成后,相同的细胞可用于其他细胞增殖测定,例如结晶紫测定,中性红测定或DNA荧光测定。(除非细胞极为稀少,不推荐。)
14. 该试剂盒可用于大肠杆菌,但不能用于酵母细胞。
15. 在读取平板之前,您可以在摇床上轻柔混匀。
16. 我们建议将细胞接种在靠近培养板中央的孔中,最外围一圈孔中的培养基容易蒸发,可以用PBS,水或培养基填充这些孔。
17. 如果您没有450nm滤光片。您也可以使用吸光度在430和490nm之间的滤光片, 450nm滤光片具有最佳灵敏度。
18. 测量450nm处的吸光度,如果您需要进行双波长测定,作为参考波长可以测定650nm处的吸光度。
19. 药物中金属离子的存在可能会影响CCK8的灵敏度。终浓度为1mM的氯化亚铅、氯化铁、硫酸铜会抑制 5%、15%、 90% 的显色反应,使灵敏度降低。如果终浓度是10mM的话,将会100%抑制。
常见问题
Q:如何做空白对照?
A:可以用加相应量细胞培养基和CCK-8但不加细胞的孔作为空白对照,若担心所使用的药物会干扰检测,需设置加相应量细胞培养液、药物和CCK-8但不加细胞的孔作为空白对照。
Q:只加CCK-8不加细胞的空白孔,数值上增?
A:在整个实验过程中,随着时间的增加,如果细胞培养时间较长,请注意蒸发问题。因为反应环境温度较高,会有部分液体挥发。空白组虽然没有细胞,但是随着液体的挥发,药物浓度相当于提高了,所以空白对照的数值也会有轻微的变化(但不会有明显的变化)。如果很在意空白对照的数值,可将96孔板外围一圈加培养基、水或PBS 保湿。同时,可以把96孔板置于培养箱内靠近水盘的位置以缓解蒸发。将96孔板外围两圈用PBS铺板,这样挥发先挥发周边的,可以对内部及空白对照的影响降至最低。
Q:一般多久测一次值?
A:预实验时可以在0.5、1、2和4小时后分别用酶标仪检测,然后选取吸光度范围比较适宜的一个时间点用于后续实验。
Q:加入CCK8后暂时不测OD值,可以如何处理暂时保存?能够保存多久?
A:如果需要暂时不测定OD值,可以向每孔中加入10ul 0.1M HCl溶液或者1% w/v的SDS溶液,避光保存在室温,24小时内吸光度不会发生变化。
Q:如何保存?
A:CCK-8溶液在避光、0-5℃的条件下可以保存1 年,若长期不用可在-20℃下避光保存2年。建议分装后保存于-20℃,使用时提前于4℃解冻,请避免反复冻融,否则增加背景值,干扰实验结果。
Q:是否需要更换培养基?
A:不需要,若药物影响比较小的情况可以不更换培养基,直接扣除培养基中加入药物后的空白吸收即可。
Q:待测物质有氧化性或还原性该做何处理?
A:本试剂盒的检测依赖于脱氢酶催化的反应,如果待测物质有氧化性或还原性,可在加CCK-8之前更换新鲜培养基,去掉药物的影响。
如果实验中有还原剂,请检查背景的OD值,即在不含细胞的培养基中加入药物,然后加入CCK-8试剂在一定时间内检测,和不加药物的培养基进行比较(只有CCK-8试剂),如果O.D值明显偏高,则说明有反应。
Q:如果培养基颜色或PH已变化,是否需要更换新的培养基?
A:加入CCK-8时,如果细胞培养时间较长,培养基颜色或pH值已变化,建议换用新鲜的培养基。
Q:适用细胞?
A:因为测线粒体酶,所以真核细胞,有线粒体的均可,例如单细胞,动物细胞。但有细胞壁的细胞,例如植物细胞,酵母细胞,底物进入细胞效率低,不推荐。
Q:线性不佳原因?
A:细胞不均;培养液蒸发;还原剂;气泡;孔板周围一圈不能用,除非只培养少于一天的时间;细胞数目很重要,太少信号会低。
Q:金属毒性?
A:可以检测金属毒性,最好做空白对照。
Q:适用于那些细胞?其他还有哪些细胞可用?生物被膜内的活菌 (流感嗜血杆菌和绿脓杆菌)?
A:所有哺乳动物的细胞,细菌一般没有检测CCK8的,可以染色法,或者流式,最常规的方法,有报道, 比浊法测OD600。
Q:是否可以替代Brud或EDU法检测细胞增殖?
A:虽然CCK8通过检测对生长期的细胞内的脱氢酶来反应细胞的活性,而胸腺嘧啶插入法通过核苷酸类似物的方式插入合成的DNA来检测细胞的活性,这几种方法是有一定关联性的,CCK8可替换胸腺嘧啶插入法来检测细胞增殖,并且检测更方便。
Q:空白孔数值偏高,有可能是培养基长菌吗?或者其他原因?
A:空白孔数值偏高一般认为染菌造成的,很少出现这种问题。
Q:CCK8能检测组织吗
A:不能检测组织。
Q:是否可以检测T细胞
A:可以,T细胞长的慢,需延长孵育时间。
Q:当两个细胞混合培养时(骨髓间充质细胞,另一个是悬浮T细胞),培养一段时间后,只测骨髓间充质干细胞的生长、增殖情况,请问用CCK-8能测吗?怎么做?
A:对于两种细胞的情况:
1)如果测定贴壁细胞的生长状况,那么可以把悬浮的T细胞转移掉,使用上述第二种方法测定。
2)如果T细胞对于间充质细胞的生长很关键,不能取走,那么测定的活性程度是总量,此时,需要对每一个孔的T细胞进行估算,如果每个培养条件下T细胞总量接近,或者T细胞含量很少,远远小于间充质细胞,也可以测定,使用对照孔可以去除T细胞的影响。
3)如果T细胞可以短时间内除去,可以找个灵敏度高的CCK-8,信号强,建议细胞量合适的情况下(每一个孔10000个),30分钟左右出读数结果,测 定后,可以将T细胞再加入培养孔。 这样做对细胞的生长影响不大。但是如果做动力学,那么要考虑的因素多一些。
Q:CCK-8是通过和细胞内的脱氢酶反应而反映着细胞数量,假如细胞已经死亡,而脱氢酶活性还有,那么如何计算细胞数量?
A:多数情况下,细胞死亡过程中,细胞内的成分会降解,脱氢酶会有部分释放,但是活性和活细胞比,比较低。举例说:100个细胞死亡20小时后,释放的脱氢酶活力,不足5个活细胞的脱氢酶活力,也就是说,这种情况带来的误差5%以内。而且,这种细胞死亡,对同种细胞来说,情况是一样的,一般都是在不同的孔间比较同种细胞,所以系统误差是一样的,即系统误差会彼此消减。
应用&特点 |
1) 细胞增殖测定 - GlpBio细胞计数试剂盒-8(CCK-8)是水溶性的,在培养中是稳定的,并且是无毒的。 2) 细胞活力测定 - 代谢活性和染料产生与改变的活力成比例地变化。 3) 细胞因子测定 - 测量细胞因子诱导的增殖。如果需要,可以在研究结束时回收细胞并扩增。 4) 细胞毒性测定 - 来自细胞毒性化学物质的细胞死亡对颜色发展没有影响,只有活细胞将试剂转化为比色指示剂。试剂本身具有可忽略的毒性,并且通常对细胞是安全的。 |
运输方式 | 蓝冰运输。 |
储存条件 | 储存在4°C避光,可稳定长达12个月。储存在-20°C避光,可稳定长达2年。 |
用途 | 仅供研究使用!不能用于人体。 |
CCK-8 | MTT | MTS | SRB |
Solubility | Water soluble | Indissolvable | Water soluble | Indissolvable |
Detection Wavelength | 450nm | 490nm | 450nm | 510nm |
Character | Liquid | Solid | Liquid | Liquid |
Usage | No need to prepare | Prepare the solutions | Use it right after it was ready | Prepared beforehand |
Need to redissolve or not | NO | Yes,by DMSO | No | Yes,by Tris-base solution |
Convenience | +++ | ++ | +++ | + |
Detection speed | +++ | + | ++ | + |
Repeatability | +++ | + | ++ | ++ |
Stability | ++ | + | + | +++ |
-
Related Biological Data
Therapeutic targeting of the DDR1–NF-κB–NRF2 axis inhibits PDAC growth and metabolism. a, Parental and E79Q KPC cells plated on wild-type or R/R ECM were incubated in LG medium with or without 7rh, ML120B or ML385. Total viable cells are presented relative to parental cells that were treated with vehicle and plated on wild-type ECM.
Cell viability was determined with a Cell Counting Kit-8 assay (Glpbio).
Nature 610.7931 (2022): 366-372. PMID: 36198801 IF: 69.5026 -
Related Biological Data
LIG1 reversed cell proliferation, apoptosis and DNA damage effects of hsa_circ_0007919 (A-B) CCK-8 analysis of the proliferation of GEM-resistant PDAC cells with or without LIG1 inhibition.
EIPA , IPI549, MBQ-167, MRT68921 or erlotinib, ML385, HCQ or their combinations were added to the wells for 24, 72 or 96 hrs. Next, 10 uL of CCK-8 (GlpBio) was added to each well.
Cancer Cell (2021). PMID: 33740421 IF: 38.5836 -
Related Biological Data
Effect of CrEL on glucose transport.Cell Counting Kit-8 (CCK-8) is a fluorescent glu-cose analog. INK-128 (mTORi) was used as a control for de-creased glucose transport.
Cells after transfection or GEM treatment were collected and counted, then 4 × 103 cells were placed into 96-well plate and cultured in incubator at 37°C. 24, 48, 72 and 96 h after, cells were incubated with 100 μl serum-free medium and 10 μl CCK-8 solution (Glpbio, USA) at 37°C for 2 h and measured at 450 nm wavelength.
Molecular Cancer, 2023, 22(1): 195. PMID: 38044421 IF: 37.2999 -
Related Biological Data
Bifidobacterium cultural supernatant and I3C protected mice against ALF. (G-H) Primary hepatocytes were pre-treated with or without I3C for 1 h followed by PBS or APAP administration for 12 h. The effects of I3C on CCK8 (G) and LDH (H) were detected. n=3-5.
Cell counting kit 8 (CCK8) experiment for in vitro assay were performed using the CCK8 Kit (Glpbio, Cat# GK10001, USA) according to the manufacturer's instructions.
Cell Host & Microbe 32.1 (2024): 48-62. PMID: 38056458 IF: 30.3013 -
Related Biological Data
Fe3O4@IR820@CpG induces immunogenic cell death and promotes DC maturation in vitro. A,B) Viability of MC38 cells after incubation with A) different concentrations of Fe3O4@IR820@CpG without laser irradiation or B) different formulations with 808 nm laser irradiation (1 W cm−2) for 5 min, as detected by CCK-8 kit (n = 4).
Bicinchoninic Acid Assay (BCA) protein assay kit,cell counting kit-8 (CCK-8), and erythrocyte membrane lysates were purchased from GlpBio (Montclair, USA).
Advanced Materials, 2023: 2307193. PMID: 37951210 IF: 29.4006 -
Related Biological Data
H) The viability ofMC38 cells treated with PAD@MS for 48 h in the presence or absence of 10 μM Ferr-1, 20 μM Nec-1, 10 μM z-VAD-FMK, and 1 mM NAC.
Cell viability was detected by cell counting kit-8 (CCK-8) assay (GlpBio, USA) according to the manufacturer’s instruction.
Adv Funct Mater, 2023: 2214998. IF: 19.9246 -
Related Biological Data
After transfection with si-1 and si-2, performed CCK-8 assays were performed to evaluate the cellular growth curves and the results revealed that repressing the expression of PCAT6 remarkably suppressed the cell proliferation of HeLa and SiHa cells.
Each well was added with 10 μl CCK-8 reagent (GLPBIO, Montclair, CA, USA) and the plates were continued to be cultured for 1-2 h. The cell viability was determined by measuring the optical density (OD) absorbance at the wavelength of 450 nm.
Eur Rev Med Pharmacol Sci.2019 Mar;23(5):1947-1956 -
Related Biological Data
Blocking bFGF leads to decrease in cell proliferation and clone formation of cisplatin (DDP) selected A549 cells. Growth curves showed that knocking down bFGF expression resulted in reduction in cell proliferation.
The cells were incubated for 24 h in incubator, and then,10μl CCK-8 (GLPBIO) was added in every well and cultivated at room temperature for 4 h. Absorbance was measured at 450 nm. The experiment repeated three times successive 7 days.
J Pharm Pharmacol.2019 Sep;71(9):1412-1420.